פלואד

Pays: Israël

Langue: hébreu

Source: Ministry of Health

Ingrédients actifs:

A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS; B/BRISBANE/60/2008 - LIKE VIRUS

Disponible depuis:

NEOPHARM SCIENTIFIC LTD

Code ATC:

J06BB07

forme pharmaceutique:

תרחיף להזרקה

Composition:

B/BRISBANE/60/2008 - LIKE VIRUS 15 MCG / 0.5 ML; A/HONG KONG/4801/2014 (H3N2) - LIKE VIRUS 15 MCG / 0.5 ML; A/CALIFORNIA/7/2009 (H1N1)PDM09-LIKE VIRUS 15 MCG / 0.5 ML

Mode d'administration:

תוך-שרירי

Type d'ordonnance:

מרשם נדרש

Fabriqué par:

SEQIRUS VACCINES LTD, UK

Groupe thérapeutique:

VACCINIA IMMUNOGLOBULIN

Domaine thérapeutique:

VACCINIA IMMUNOGLOBULIN

indications thérapeutiques:

Active immunisation against influenza in theelderly (65 years of age and over), especially for those with an infreased risk of associated complications (i.e. patients affected by underlying chronic diseases including diabetes, cardiovascular and respiratory diseases).

Date de l'autorisation:

2015-12-31